Top Industry Leaders in the Hirsutism Treatment Market
Latestย Hirsutism Treatmentย Companiesย Updates:
Elnora Pharmaceuticals Inc. (US) Received FDA approval for its VIOKALโข (elagolix), a once-daily oral medication for the treatment of moderate-to-severe hirsutism in women with androgen excess (Jan 2024).
Bayer AG (Germany) Announced positive Phase 3 data for its investigational oral androgen receptor antagonist (OAR), KAE-779, for the treatment of hirsutism in women with PCOS (Dec 2023).
Lutronic Corporation (South Korea) Launched its SpectraLite Versaโข IPL hair removal system for professional and home use, offering a safe and effective option for managing unwanted hair growth associated with hirsutism (Nov 2023).
Candela Corporation (US) Introduced its GentleMax Pro Plusยฎ laser system with advanced features for permanent hair reduction, catering to the growing demand for minimally invasive hirsutism treatments (Oct 2023).
List ofย Hirsutism Treatmentย Key companies in the market:
- AbbVie Inc. (US)
- Allergan (Republic of Ireland)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (US)
- Jubilant Cadista (US)
- Pfizer Inc. (US)
- Sun Pharmaceutical Industries Ltd. (India)